Teacher Retirement System of Texas increased its position in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 62.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 113,025 shares of the company's stock after buying an additional 43,531 shares during the period. Teacher Retirement System of Texas owned about 0.06% of Doximity worth $6,034,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also modified their holdings of the company. Harvest Fund Management Co. Ltd raised its holdings in Doximity by 198.1% in the 4th quarter. Harvest Fund Management Co. Ltd now owns 26,889 shares of the company's stock valued at $1,435,000 after acquiring an additional 17,869 shares during the last quarter. Xponance Inc. grew its position in shares of Doximity by 9.2% in the fourth quarter. Xponance Inc. now owns 15,307 shares of the company's stock valued at $817,000 after purchasing an additional 1,291 shares during the period. Thrivent Financial for Lutherans increased its stake in Doximity by 31.0% in the fourth quarter. Thrivent Financial for Lutherans now owns 40,609 shares of the company's stock valued at $2,169,000 after purchasing an additional 9,618 shares during the last quarter. Counterpoint Mutual Funds LLC purchased a new position in Doximity during the fourth quarter worth about $1,820,000. Finally, Corient Private Wealth LLC boosted its stake in Doximity by 3.9% in the 4th quarter. Corient Private Wealth LLC now owns 8,887 shares of the company's stock worth $474,000 after buying an additional 334 shares during the last quarter. Hedge funds and other institutional investors own 87.19% of the company's stock.
Doximity Stock Performance
Shares of NASDAQ DOCS traded down $0.89 during midday trading on Thursday, reaching $60.59. 2,240,844 shares of the company's stock were exchanged, compared to its average volume of 1,898,744. The stock has a market capitalization of $11.31 billion, a PE ratio of 60.59, a price-to-earnings-growth ratio of 4.10 and a beta of 1.34. Doximity, Inc. has a 52-week low of $22.96 and a 52-week high of $85.21. The business's fifty day moving average price is $65.24 and its two-hundred day moving average price is $54.11.
Wall Street Analyst Weigh In
A number of research firms have recently commented on DOCS. Mizuho upped their price objective on shares of Doximity from $55.00 to $65.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Leerink Partnrs upgraded Doximity from a "hold" rating to a "strong-buy" rating in a report on Friday, February 7th. Wells Fargo & Company reiterated an "equal weight" rating on shares of Doximity in a report on Friday, February 7th. Stephens initiated coverage on shares of Doximity in a report on Friday, December 20th. They issued an "equal weight" rating and a $55.00 price target on the stock. Finally, Raymond James reiterated an "outperform" rating and set a $83.00 price objective (up from $65.00) on shares of Doximity in a research note on Friday, February 7th. Eleven analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, Doximity currently has an average rating of "Moderate Buy" and an average price target of $64.22.
Read Our Latest Research Report on DOCS
Insiders Place Their Bets
In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the company's stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the transaction, the director now directly owns 6,360 shares of the company's stock, valued at $366,463.20. This represents a 75.87 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 37.40% of the stock is owned by company insiders.
About Doximity
(
Free Report)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Read More
Before you consider Doximity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.
While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
